SEC CHARGES ZYMERGEN INC. WITH MISLEADING IPO INVESTORS ABOUT COMPANY"S MARKET POTENTIAL AND SALES PROSPECTS

The Securities and Exchange Commission announced settled charges against Zymergen Inc., an Emeryville, California-based biotechno...


You need to be a subscriber to view this article. It's free!

CN Editor

September 16, 2024